Statements of Cash Flows

(Millions of Yen)

Please scroll horizontally to look at table below.

2018/3 2019/3 2020/3 2021/3 2022/3
Cash flows from operating activities
Income before income taxes and minority interests 4,746 5,838 3,920 2,840 2,711
Depreciation 817 906 912 1,061 1,298
Impairment loss 1 - - 1 -
Amortization of goodwill 65 64 63 62 99
Increase(decrease) in allowance for doubtful accounts 48 26 -50 7 -52
Increase (decrease) in provision for directors' bonuses -0 0 3 0 -7
Increase(decrease) in provision for directors' retirement benefits - -8 - - -
Increase (decrease) in provision for Executive share benefits (and other officers) - 72 24 89 18
Increase (decrease) in net defined benefit liability 5 5 -5 9 20
Interest and dividends income -110 -121 -175 -99 -148
Interest expenses 0 0 10 26 40
Decrease (increase) in notes and accounts receivable - trade -2,259 -2,331 3,381 2,661 389
Decrease (increase) in inventories -207 -902 -645 -299 ‐2,388
Increase(decrease) in notes and accounts payable-trade 722 827 -778 -2,000 545
Other 803 98 -489 -554 97
Subtotal 4,633 4,476 6,172 3,806 2,624
Interest and dividends income recieved 118 98 197 98 197
Interest expenses paid -0 -0 -8 -26 -41
Income taxes (paid) refund -785 -1,557 -1,490 -836 -761
Net cash provided by (used in) operating activities 3,965 3,017 4,870 3,041 2,018
Cash flows from investing activities
Net decrease (increase) in time deposits -16 16 - - -
Net decrease (increase) in trust beneficiary right -87 74 101 315 -65
Net decrease (increase) in short-term investment securities 300 - - - -
Purchases of property,plant and equipment and intangible assets -499 -558 -1,765 -1,711 -680
Proceeds from sales of property, plant and equipment and intangible assets 32 2 1 10 5
Purchases of investment securities - - -280 -70 -
Proceeds from sales and redemptions of investments securities 1 0 0 14 643
Payments for investments in capital - - - -593 -
Payments of loans receivable - - -0 - -
Collection of loans receivable 1 0 0 0 0
Purchase of shares of subsidiaries resulting in change in scope of consolidation - - - - -846
Other - -98 - - 10
Net cash provided by (used in) investing activities -269 -562 -1,942 -2,034 -932
Cash flows from financing activities
Cash dividends paid -1,002 -1,372 -1,562 -1,288 -1,346
Net increase (decrease) in short-term borrowings - - 234 -99 -152
Proceeds from long-term loans payable - - 471 - -
Repayment of long-term loans payble - - -30 -53 -76
Purchase of treasury shares -1 -0 ‐0 -0 -1,066
Proceeds from disposal of treasury shares 3 - 0 - -
Other -18 -26 -44 -60 ‐188
Net cash provided by (used in) financing activities -1,019 -1,399 -931 -1,503 -2,830
Effect of exchange rate change on cash and cash equivalents 31 -89 -146 277 600
Net increase(decrease) in cash and cash equivalents 2,709 965 1,850 -218 -1,144
Cash and cash equivanents and beginning of year 11,254 13,963 14,929 16,779 17,301
Cash and cash equivanents of newly consolidated subsidiaries(Increase in cash and cash equivalents resulting from merger with unconsolidated subsidiaries) - - - 740 -
Cash and cash equivalents
at end of period
13,963 14,929 16,779 17,301 16,157
  • *1 The Financial Statements have been compiled based on the items disclosed in the Summary of Financial Results for each report period, and the items presented have been based on the most recent Summary of Financial Results. Therefore, the items presented in the form of a bar (“-“) may be included under the category "Other."
  • *2 2019/3 was an irregular 15-month fiscal period for overseas consolidated subsidiaries.